Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.

The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:

Salvatore Albani Declared also to be a member of Ardimedes Consulting.

Carl Anderson Declared no potential conflict of interest.

Robert L. Coffman Declared to be stakeholder in a company as employee of Dynavax Technologies.

Giancarlo Comi Declared receipt of honoraria from Serono Symposia International Foundation, Bayer Schering, Merck Serono, TEVA Pharmaceuticals Ind. Ltd, Sanofi Aventis and Biogen Dompè.

Francesco Cucca Declared no potential conflict of interest.

Claudio Fiocchi Declared no potential conflict of interest.

Cecilia Garlanda Declared no potential conflict of interest.

Paolo Gionchetti Declared a participation in a company sponsored speaker’s bureau to Ferring Symposium.

David Hafler Declared receipt grant and contracts NIH/NINDS R37 NS024247 NIH/NINDS P01 NS 038037 NIH/NINDS R01 NS 049477 NIH (U19 AI 070352) NIH (P01 AI 073748), receipt of honoraria or consultation fees from: Allozyne Inc, EISAI Research Institute, Xceed Corp (honoraria for consulting 2009).

Hans Peter Hartung Declared receipt of honoraria or consultation fee from: Biogen Idec, Teva Sanofi Aventis, Merck Serono, Novartis, Bayer Health Care.

Ruggero Pardi Declared no potential conflict of interest.

Virginia Pascual Declared receipt of honoraria: contract with Medimmune.

Vito Pistoia Declared no potential conflict of interest.

Sergio Romagnani Declared no potential conflict of interest.

Maria Grazia Roncarolo Declared no potential conflict of interest.

Riccardo Troncone Declared no potential conflict of interest.

Matthias von Herrath Declared no potential conflict of interest.

The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of April 12, 2010.

Luciano Adorini